Novel protein, antisense to C15orf39 (ENSG00000261779)

ENSG00000261779 is a non-coding RNA annotated as "Novel protein, antisense to C15orf39." It represents a transcript located antisense to the C15orf39 locus on human chromosome 15, but it does not currently have any characterized biological function, protein product, or therapeutic relevance. Its role, if any, remains unknown. The related protein-coding gene C15orf39 is under investigation for its role in inflammation and central nervous system diseases, but this does not extend to the antisense RNA[3][1]. ENSG00000261779 does not encode a protein; its name is a descriptive placeholder reflecting its antisense relationship to C15orf39[3]. If you are seeking information on a therapeutic target related to inflammation or disease, research should focus on the C15orf39 protein rather than the antisense RNA. C15orf39 protein interacts with PRMT2, regulates NF-κB signaling, and is under investigation as a therapeutic target for inflammation—particularly in microglia and central nervous system disease contexts[1]. Per standard protein nomenclature guidelines, non-coding RNAs like ENSG00000261779 are not considered classic receptors, enzymes, or drug targets[4]. In summary, ENSG00000261779 refers to an antisense RNA transcript, not a therapeutic target, protein, or receptor. There is no evidence it is druggable or involved in disease, nor does it have validated aliases beyond the descriptive name. The function and disease relevance remain unknown, with research focused on its sense counterpart, C15orf39[3][1].

Other names

Novel protein, antisense to C15orf39ENSG00000261779

No known mechanism because it is a non-coding RNA.